adenosine diphosphate ribose has been researched along with irinotecan in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belogurov, AA; Chen, G; Chen, Z; He, Q; Li, X; Lin, S; Liu, Y; Tian, J; Yang, M; Zhang, F | 1 |
1 other study(ies) available for adenosine diphosphate ribose and irinotecan
| Article | Year |
|---|---|
SN-38 Sensitizes BRCA-Proficient Ovarian Cancers to PARP Inhibitors through Inhibiting Homologous Recombination Repair.
Topics: Adenosine Diphosphate Ribose; Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; DNA; Female; Humans; Irinotecan; Ovarian Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Recombinational DNA Repair | 2022 |